Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A Fundamental Analysis
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A (BRKRP) shows moderate financial fundamentals with a PE ratio of -649.45, profit margin of -0.25%, and ROE of -0.40%. The company generates $3.4B in annual revenue with strong year-over-year growth of 13.56%.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 33.7/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze BRKRP's fundamental strength across five key dimensions:
Efficiency Score
WeakBRKRP struggles to generate sufficient returns from assets.
Valuation Score
ModerateBRKRP shows balanced valuation metrics.
Growth Score
ModerateBRKRP shows steady but slowing expansion.
Financial Health Score
ExcellentBRKRP maintains a strong and stable balance sheet.
Profitability Score
WeakBRKRP struggles to sustain strong margins.
Key Financial Metrics
Is BRKRP Expensive or Cheap?
P/E Ratio
BRKRP trades at -649.45 times earnings. This suggests potential undervaluation.
PEG Ratio
When adjusting for growth, BRKRP's PEG of 5.31 indicates potential overvaluation.
Price to Book
The market values Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A at 2.27 times its book value. This may indicate undervaluation.
EV/EBITDA
Enterprise value stands at 12.95 times EBITDA. This signals the market has high growth expectations.
How Well Does BRKRP Make Money?
Net Profit Margin
For every $100 in sales, Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A keeps $-0.25 as profit after all expenses.
Operating Margin
Core operations generate 5.44 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $-0.40 in profit for every $100 of shareholder equity.
ROA
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates $-0.14 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates limited operating cash flow of $133.93M, signaling weaker underlying cash strength.
Free Cash Flow
Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A generates weak or negative free cash flow of $43.24M, restricting financial flexibility.
FCF Per Share
Each share generates $0.28 in free cash annually.
FCF Yield
BRKRP converts 0.78% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
-649.45
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
5.31
vs 25 benchmark
P/B Ratio
Price to book value ratio
2.27
vs 25 benchmark
P/S Ratio
Price to sales ratio
1.63
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.83
vs 25 benchmark
Current Ratio
Current assets to current liabilities
1.73
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
-0.00
vs 25 benchmark
ROA
Return on assets percentage
-0.00
vs 25 benchmark
ROCE
Return on capital employed
0.04
vs 25 benchmark
How BRKRP Stacks Against Its Sector Peers
| Metric | BRKRP Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | -649.45 | 28.81 | Better (Cheaper) |
| ROE | -0.40% | 643.00% | Weak |
| Net Margin | -0.25% | -44312.00% (disorted) | Weak |
| Debt/Equity | 0.83 | 0.36 | Weak (High Leverage) |
| Current Ratio | 1.73 | 4.50 | Neutral |
| ROA | -0.14% | -17799.00% (disorted) | Weak |
BRKRP outperforms its industry in 1 out of 6 key metrics, but lagging in ROE.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Bruker Corporation 6.375% Mandatory Convertible Preferred Stock, Series A's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
69.18%
Industry Style: Defensive, Growth, Innovation
High GrowthEPS CAGR
-40.26%
Industry Style: Defensive, Growth, Innovation
DecliningFCF CAGR
22.66%
Industry Style: Defensive, Growth, Innovation
High Growth